Wedbush Downgrades Anadys Pharmaceuticals (ANDS) to Neutral; Announces Acquisition by Roche; Additional Takeover Targets Remain

Go back to Wedbush Downgrades Anadys Pharmaceuticals (ANDS) to Neutral; Announces Acquisition by Roche; Additional Takeover Targets Remain
Achillion Pharmaceuticals, Inc. (AMEX: ACHN) Delayed: 0.79 --0 (-0%)
Previous Close $0.79    52 Week High $10.95 
Open $15.10    52 Week Low $3.78 
Day High $0.79    P/E N/A 
Day Low $0.79    EPS $-0.63 
Volume 504,330       

Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) Delayed: 3.70 --0 (-0%)
Previous Close $3.70    52 Week High $3.70 
Open $26.00    52 Week Low $0.60 
Day High $3.70    P/E N/A 
Day Low $3.70    EPS $-0.43 
Volume 900       

Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) Delayed: 24.50 --0 (-0%)
Previous Close $24.50    52 Week High $24.50 
Open $9.18    52 Week Low $4.81 
Day High $24.50    P/E N/A 
Day Low $24.50    EPS $-0.89 
Volume 5,300       

Inhibitex, Inc. (NASDAQ: INHX) Delayed: 26.00 --0 (-0%)
Previous Close $26.00    52 Week High $26.01 
Open $1.33    52 Week Low $2.15 
Day High $26.00    P/E N/A 
Day Low $26.00    EPS $-0.38 
Volume 470,537